Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

ClinicalTrials.gov ID: NCT06830044

Public ClinicalTrials.gov record NCT06830044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 12, 2026, 9:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive Disorder

Study identification

NCT ID
NCT06830044
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2025
Primary completion
Feb 29, 2028
Completion
Feb 29, 2028
Last update posted
Feb 26, 2026

2025 – 2028

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Vanda Investigational Site Phoenix Arizona 85012 Recruiting
Vanda Investigational Site Little Rock Arkansas 72211 Recruiting
Vanda Investigational Site Garden Grove California 92845 Recruiting
Vanda Investigational Site Lemon Grove California 91945 Recruiting
Vanda Investigational Site Orange California 92868 Recruiting
Vanda Investigational Site San Jose California 95124 Recruiting
Vanda Investigational Site Walnut Creek California 94596 Recruiting
Vanda Investigational Site Colorado Springs Colorado 80910 Recruiting
Vanda Investigational Site Fort Myers Florida 33912 Recruiting
Vanda Investigational Site Miami Florida 33135 Active, not recruiting
Vanda Investigational Site Miami Florida 33173 Recruiting
Vanda Investigational Site Tampa Florida 33614 Active, not recruiting
Vanda Investigational Site Chicago Illinois 60634 Recruiting
Vanda Investigational Site Saint Charles Missouri 63304 Recruiting
Vanda Investigational Site Las Vegas Nevada 89119 Recruiting
Vanda Investigational Site New York New York 10035 Recruiting
Vanda Investigational Site Staten Island New York 10314 Recruiting
Vanda Investigational Site Media Pennsylvania 19063 Recruiting
Vanda Investigational Site Richardson Texas 75080 Recruiting
Vanda Investigational Site Witchita Falls Texas 76309 Recruiting
Vanda Investigational Site Bellevue Washington 98007 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06830044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06830044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →